What is Ethos Laboratories?
Founded in 2010, Ethos Laboratories operates as a CAP-accredited and CLIA-certified facility, providing a robust suite of advanced diagnostic services. The company specializes in clinical toxicology, biomarker testing, pharmacogenetics, and infectious disease diagnostics. By delivering high-precision biochemical assessments and adherence monitoring, Ethos Labs empowers healthcare providers to make data-driven, personalized treatment decisions. Their commitment to diagnostic intelligence serves as a cornerstone for improving patient outcomes across diverse medical conditions, establishing the firm as a critical partner in modern healthcare delivery.
How much funding has Ethos Laboratories raised?
Ethos Laboratories has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Ethos Laboratories
PPP
Public-Private Partnership
What's next for Ethos Laboratories?
With this recent infusion of capital, Ethos Laboratories is expected to scale its research and development initiatives, focusing on the integration of next-generation diagnostic technologies. The strategic roadmap likely involves expanding their laboratory capacity to meet the growing demand for personalized medicine and pharmacogenetic insights. As the company continues to refine its diagnostic intelligence, it remains well-positioned to capture additional market share in the competitive clinical testing industry, potentially exploring new partnerships to enhance its service delivery model and operational efficiency.
See full Ethos Laboratories company page
